BIOTECHNOLOGY

World Nutrition: Insects will be on every table

Bioeconomy: It could be a turning point for the fish meal and fish oil dependent animal feed industry in Europe. Since July, the European Commission has allowed the use of insect-processed...

Amsterdam applauded as new EMA headquarters

Amsterdam has beaten Milan and Copenhagen in the race to become the European Medicines Agency's new home. Pharma and biotech stakeholders applauded the vote as Amsterdam achieved the hightest rate...

CHMP recommends EU marketing approval of ten drugs

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended seven medicines for approval, including two orphan medicines, plus three generics at its November 2017 meeting.

FDA lifts clinical hold on Cellectis Phase I trials

The US Food and Drug Administration (FDA) has lifted the clinical hold due to a patient death on Phase I testing of UCART123 in acute myeloid leukemia (AML) and blastic...

European biotech stocks: New wave of optimism

In 2017, the European biotech sector witnessed a volume increase in IPOs and follow-on financings. This says the most recent capital market report of BIOCOM which is published during BIO-Europe...

Blocking antibody recycling vs autoimmune diseases

Researchers at Belgian UCB SA have clinically demonstrated that an antibody targeting a normal cellular recycling process can remove autoantibodies from the blood of people with autoimmune diseases. In...

11th Berlin Conference on Life Sciences: Novel antimicrobials and AMR...

02.03.2018 Over it’s ten year’s history, the Berlin Conference has become a must-attend event for Life Science decision makers, business developers, investors and legal experts. The 11th conference will...

Uniqure readies share stock offering

Dutch Uniqure BV launched a public offering of five million shares of common stock. Underwriters over-allotment will be an additional 750,000 shares. Following up on its well-received lead programme switch,...

ADC Therapeutics raises US$200m in private financing

Swiss cancer antibody-drug conjugate (ADC) developer ADC Therapeutics Sarl (Epalinges) has raised US$200m million through an oversubscribed private placement. Investors  include Auven Therapeutics, Redmile, the Wild Family Office and its...
Biotechnology : nature.com


Nature Biotechnology journal featuring biotechnology articles and science research papers of commercial interest in pharmaceutical, medical, and environmental sciences.

Visualizing detailed postdoctoral employment trends using a new career outcome...

Visualizing detailed postdoctoral employment trends using a new career outcome taxonomyVisualizing detailed postdoctoral employment trends using a new career outcome taxonomy, Published online: 15 January 2018; doi:10.1038/nbt.4059A standard taxonomy and...

Scaffolds that mimic antigen-presenting cells enable <i>ex vivo</i> expansion of...

Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cellsScaffolds that mimic antigen-presenting cells enable <i>ex vivo</i> expansion of primary T cells, Published online: 15 January 2018;...

Dual gene activation and knockout screen reveals directional dependencies in...

Dual gene activation and knockout screen reveals directional dependencies in genetic networksDual gene activation and knockout screen reveals directional dependencies in genetic networks, Published online: 15 January 2018; doi:10.1038/nbt.4062Combining gene...

PODCAST: First rounders: Susan Windham-Bannister

PODCAST: First rounders: Susan Windham-BannisterPODCAST: First rounders: Susan Windham-Bannister, Published online: 10 January 2018; doi:10.1038/nbt.4053PODCAST: First rounders: Susan Windham-Bannister

Mapping the global influence of published research on industry and...

Mapping the global influence of published research on industry and innovationMapping the global influence of published research on industry and innovation, Published online: 10 January 2018; doi:10.1038/nbt.4049Measuring citations to scholarly...

With a free pass, CRISPR-edited plants reach market in record...

With a free pass, CRISPR-edited plants reach market in record timeWith a free pass, CRISPR-edited plants reach market in record time, Published online: 10 January 2018; doi:10.1038/nbt0118-6bWith a free pass,...

Why the European Union needs a national GMO opt-in mechanism

Why the European Union needs a national GMO opt-in mechanismWhy the European Union needs a national GMO opt-in mechanism, Published online: 10 January 2018; doi:10.1038/nbt.4051Why the European Union needs a...

First <i>in vivo</i> human genome editing trial

First in vivo human genome editing trialFirst <i>in vivo</i> human genome editing trial, Published online: 10 January 2018; doi:10.1038/nbt0118-5bFirst in vivo human genome editing trial